CSNK1E/CTNNB1 Are Synthetic Lethal To TP53 in Colorectal Cancer and Are Markers for Prognosis
Open Access
Abstract
No abstract availableKeywords
Funding Information
- China Medical University Hospital (DMR-103-017)
This publication has 43 references indexed in Scilit:
- A colorectal cancer classification system that associates cellular phenotype and responses to therapyNature Medicine, 2013
- Synthetic Lethal Screen of an EGFR-Centered Network to Improve Targeted TherapiesScience Signaling, 2010
- DNA Polymerases as Potential Therapeutic Targets for Cancers Deficient in the DNA Mismatch Repair Proteins MSH2 or MLH1Cancer Cell, 2010
- Colorectal Cancer Epidemiology: Incidence, Mortality, Survival, and Risk FactorsClinics in Colon and Rectal Surgery, 2009
- Unique microRNA molecular profiles in lung cancer diagnosis and prognosisCancer Cell, 2006
- Combining biological networks to predict genetic interactionsProceedings of the National Academy of Sciences, 2004
- Cyclooxygenase-2 Induces EP1- and HER-2/Neu-Dependent Vascular Endothelial Growth Factor-C Up-RegulationCancer Research, 2004
- Cell lineage-specific effects associated with multiple deficiencies of tumor susceptibility genes in Msh2(-/-)Rb(+/-) mice.2002
- Systematic Genetic Analysis with Ordered Arrays of Yeast Deletion MutantsScience, 2001
- IC261, a specific inhibitor of the protein kinases casein kinase 1-delta and -epsilon, triggers the mitotic checkpoint and induces p53-dependent postmitotic effectsOncogene, 2000